Company · CIK 0001107421 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Alaunos Therapeutics, Inc. · TCRT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 AForm 4 → | Aug 11, 4:15 pm EDT | Holger WeisCEO | 4,363 | $2.01 | $8,770 | 25,483 | — | late |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:15 pm EDT | Michael Allen JermanDirector | 8,138 | $1.92 | $15,625 | 23,759 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:15 pm EDT | Holger WeisCEO | 4,568 | $1.92 | $8,771 | 21,120 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:15 pm EDT | Robert W PostmaDirector | 8,463 | $1.92 | $16,249 | 58,609 | — | |
| Jul 23, 2026 AForm 4 → | Jul 27, 4:15 pm EDT | Jaime VieserDirector | 8,789 | $1.92 | $16,875 | 47,642 | — | |
| Jun 30, 2026 AForm 4 → | Jul 2, 5:33 pm EDT | Holger WeisChief Executive Officer | 3,880 | $2.26 | $8,769 | 16,552 | — | |
| Jun 12, 2026 AForm 4 → | Jun 17, 4:47 pm EDT | Holger WeisChief Executive Officer | 7,761 | $2.26 | $17,540 | 12,672 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.